SUBSCRIBE
SUBSCRIBE

BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
11 Results
Year
Month
Day
Year
Month
Day
  • Drug Development
    US Partial Clinical Hold on Diamyd® Phase III Trial Lifted by the FDA
    Diamyd Medical announced that the U.S. Food and Drug Administration has lifted the partial clinical hold on the confirmatory Phase III trial DIAGNODE-3, evaluating the safety and efficacy of the precision medicine and antigen-specific immunotherapy Diamyd® in individuals recently diagnosed with type 1 diabetes.
    November 27, 2022
     · 
    3 min read